Arabic Arabic English English French French German German
dark

Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion

Extension means the ‘majority’ of people aged 12 years and older with CF in Europe can now access therapy Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021

Next Post

First UK-based clinical trial focused viral vector manufacturer announces launch

Related Posts
Total
0
Share